Chronic ostructive pulmonary disease epidemiology;L'epidemiologia della broncopneumopatia cronica ostruttiva

Minerva Pneumologica

Volumn 42, Issue 3, 2003, Pages 67-84

  Matteelli, G ^a   Scognamiglio, A ^a   Pistelli, F ^b   Baldacci, S ^a   Carrozzi, L ^b   Viegi, G ^a  

^a CNR   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Air pollution; Chronic obstructive pulmonary disease; Epidemiology; Morbidity; Mortality; Smoking

Indexed keywords

AIR POLLUTION; ALCOHOL CONSUMPTION; CAUSE OF DEATH; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DEVELOPING COUNTRY; EMPHYSEMA; HEREDITY; HUMAN; INDUSTRIALIZATION; MORBIDITY; MORTALITY; NUTRITIONAL STATUS; OCCUPATIONAL EXPOSURE; PATHOGENESIS; PREVALENCE; REVIEW; RISK FACTOR; SOCIAL STATUS;

EID: 0345305328     PISSN: 00264954     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. CIBA Foundation Guest Symposium. Terminology, definitions and classification of chronic pulmonary emphysema and related conditions. Thorax 1959;14:286-99.
2. American College of Chest Physicians-American Thoracic Society. Pulmonary terms and symbols. Chest 1975;67:583-93.
3. th revision. Geneva: WHO; 1977.
4. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
5. th Revision. Geneva: World Health Organization; 1992.
6. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020. Lancet 1997;349:1498-504.
7. Hoyert DL, Arias E, Smith BL, Murphy SL, Kochanek KD. Deaths: Final data for 1999. Nat Vital Stat Rep 2001;49:1-13.
8. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 2002;51:1-16.
9. Anderson RN. Deaths: leading causes for 2000. Nat Vital Stat Rep 2002;50:1-12.
10. Izumi T. Chronic obstructive pulmonary disease in Japan. Curr Opin Pulm Med 2002;8:102-5.
11. Hurd SS. International efforts directed at attacking the problem of COPD. Chest 2000;117:336s-8s.
12. Dati Istituto Superiore di Sanità. La mortalità per causa in Italia: 1980-1998. Sito Internet: www.mortalita.iss.it
13. Camilli AE, Robbins DR, Lebowitz MD. Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol 1991;133:795-800.
14. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: Data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000;160:1683-9.
15. Lacasse Y, Brooks D, Goldstein RS. Trends in the epidemiology of COPD in Canada, 1980 to 1995. COPD and Rehabilitation Committee of the Canadian Thoracic Society. Chest 1999;116:306-13.
16. Viegi G, Paoletti P, Carrozzi L, Vellutini M, Diviggiano E, Di Pede F et al. Prevalence rates of respiratory symptoms in Italian general population samples, exposed to different levels of air pollution. Environ Health Persp 1991;94:95-9.
17. Lundback B, Nystrom L, Rosenhall L, Stjernberg N. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J 1991;4:257-66.
18. Enright PL, Kronmal RA, Higgins MW, Schenker MB, Haponik EF. Prevalence and correlates of respiratory symptoms and disease in the elderly. Chest 1994;106:827-34.
19. Stang P, Lydick E, Silberman C, Kempel A, Keating ET. The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. Chest 2000;117:354s-9s.
20. Viegi G, Pedreschi M, Pistelli F, Di Pede F, Baldacci S, Carrozzi L et al. Prevalence of airway obstruction in a general population sample. European Respiratory Society vs American Thoracic Society definition. Chest 2000;117:339s-45s.
21. ISTAT. Indagine multiscopo sulle famiglie «Condizioni di salute della popolazione». 1999-2000.
22. Dati del Ministero della Salute. Ricoveri Ospedalieri-Anno 2000. Sito internet: www.ministerosalute.it
23. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observation on male British doctors. Br Med J 1994;309:901-11.
24. Lam TH, He Y, Li LS, Li LS, He SF, Liang BQ. Mortality attributable to cigarette smoking in China. JAMA 1997;278:1505-8.
25. Viegi G, Paoletti P, Vellutini M, Carrozzi L, Di Pede F, Baldacci S et al. Effects of daily cigarette consumption on respiratory symptoms and lung function in a general population sample of North-italian men. Respiration 1991;58:282-6.
26. US Public Health Service. The health consequences of smoking. Chronic obstructive lung disease. A report of the surgeon general. Rockville: Department of Health and Human Services, Public Health Service, Office on Smoking and Health; 1984,1-512.
27. Doll R. Risk from tobacco and potentials for health gain. Int J Tuberc Lung Dis 1999;3:90-9.
28. Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States, 1995-1999. MMWR Mob Mortal Wkly Rep 2002;51:300-3.
29. Thun MJ, Apicella LF, Henley SJ. Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom. JAMA 2000;284:706-12.
30. Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidem 2000;53:755-61.
31. Lacroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berlman L et al. Smoking and mortality among older men and women in three communities. N Engl J Med 1991;324:1619-25.
32. Marang-van de Mheen PJ, Davey Smith G, Hart CL, Hole DJ. Are women more sensitive to smoking than men? Findings from the Renfrew and Paisley study. Int J Epidemiol 2001;30:787-92.
33. Tishler PV, Carey VJ, Reed T, Fabsitz RR. The role of genotype in determining the effects of cigarette smoking on pulmonary function. Genet Epidemiol 2002;22:272-82.
34. Viegi G, Carrozzi L, Pistelli F, Scognamiglio A, Baldacci S. Prevalenza e fattori di rischio acquisiti delle BPCO. In: Giuntini C, Grassi G editors. «Il volto della BPCO che cambia». Vol 1. UTET; 2001,p.49-66.
35. Viegi G, Paoletti P, Prediletto R, Carrozzi L, Fazzi P, Di Pede F et al. Prevalence of respiratory symptoms in an unpolluted area of Northern Italy. Eur Respir J 1988;1:311-8.
36. Viegi G, Carrozzi L, Pedreschi M, Baldacci S, Modena P, Vellutini M et al. Prevalence rates of respiratory symptoms in two general population samples exposed to different levels of air pollution. Am J Respir Crit Care Med 1995;151:A281.
37. Viegi G, Paoletti P, Carozzi L, Baldacci S, Modena P, Pedreschi M et al. CO diffusing capacity in a general population sample: relationship with cigarette smoking and airflow obstruction. Respiration 1993;60:155-61.
38. Becklake MR. Occupational exposure: evidence for a causal association with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989;140:85s-91s.
39. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P et al. On behalf of the Task Force. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995;8:1398-420.
40. Viegi G, Di Pede C. Chronic obstructive lung disease and occupational exposure. Curr Opin Allergy Clin Immunol 2002;2:115-21.
41. Hnizdo E, Sullivan PA, Bang KM, Wagner G. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2002;156:738-46.
42. 1 and subsequent respiratory symptoms, illnesses, and mortality in coal miners in the United States. Am J Respir Crit Care Med 2001;163:633-9.
43. American Thoracic Society (ATS). What constitutes and adverse health effect of air pollution? Am J Respir Crit Care Med 2000;161:665-73.
44. Brunekreef B, Holgate ST. Air pollution and health. Lancet 2002;360:1233-42.
45. Viegi G, Baldacci S. Epidemiological studies of chronic respiratory conditions in relation to urban air pollution in adults. In: D'Amato G, Holgate ST editors. The impact of air pollution on respiratory health. Eur Respir Mon 2002;21:1-16.
46. Viegi G. Non-carcinogenic health effects of air pollution: a european perspective. Tub Lung Dis 1994;75:83-4.
47. Committee of the Environmental and Occupational Health Assembly of the American Thoracic Society. Health effects of outdoor air pollution. Am J Respir Crit Care Med 1996;153:3-50.
48. Schwartz J, Dockery DW, Neas LM. Is daily mortality associated specifically with fine particles? J Air Waste Manag Assoc 1997;46:927-39.
49. Laden F, Neas LM, Dockery DW, Schwartz J. Association of fine particulate matter from different sources with daily mortality in six U.S. cities. Environ Health Perspect 2000;108:941-7.
50. rd, Xu X, Spengler JD, Ware JH, Fay ME et al. An association between air pollution and mortality in six U.S. Cities. N Engl J Med 1993;329:1753-9.
51. rd, Thun MJ, Namboodiri MM, Dockery DW, Evans JS, Speizer FE et al. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med 1995;151:669-74.
52. Nyberg F, Gustavsson P, Jarup L, Bellander T, Berglind N, Jakobsson R et al. Urban air pollution and lung cancer in Stockholm. Epidemiology 2000;11:487-95.
53. 2.5) and other air pollutants. J Exp Anal Environ Epidemiol 1995;5:137-59.
54. Viegi G, Pedreschi M, Baldacci S, Chiaffi L, Pistelli F, Modena P et al. Prevalence rates of respiratory symptoms and diseases in general population samples of North and Central Italy. Int J Tuberc Lung Dis 1999;3:1034-42.
55. Ackermann-Liebrich U, Leuenberger P, Schwartz J, Schindler C, Monn C, Bolognini G et al. Lung function and long term exposure to air pollutants in Switzerland. Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) Team. Am J Respir Crit Care Med 1997;155:122-9.
56. Künzli N, Kaiser R, Medina S, Studnicka M, Chanel O, Filliger P et al. Public-health impact of outdoor and traffic-related air pollution: a European assessment. Lancet 2000;356:795-801.
57. rd, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002;287:1132-41.
58. Hoek G, Brunekreef B, Goldbohm S, Fischer P, van den Brandt PA. Association between mortality and indicators of traffic-ralated air pollution in the Netherlands: a cohort study. Lancet 2002;360:1203-9.
59. rd. Acute respira-tory effects of particulate air pollution. Annu Rev Public Health 1994;15:107-32.
60. Katsouyanni K, Touloumi G, Samoli E, Gryparis A, Le Tertre A, Monopolis Y et al. Confounding and effect modification in the short term effects of ambient particles on total mortality: results from 29 European cities within the APHEA-2 project. Epidemiology 2001;12:521-3.
61. Schwartz J. Air pollution and hospital admission for respiratory disease. Epidemiology 1996;7:20-8.
62. McConnell R, Berhane K, Gilliland F, London SJ, Islam T, Gaudennan WJ et al. Asthma in exercising children exposed to ozone: a cohort study. Lancet 2002;359:386-91.
63. Harrison PTC. Lifestyle and indoor air pollution: irritative agents. In: D'Amato G, Holgate ST, editors. "The impact of air pollution on respiratory health". Eur Respir Mon 2002;7:117-32.
64. Simoni M, Biavati P, Carrozzi L, Viegi G, Paoletti P, Matteucci G et al. The Po River Delta (North Italy) Indoor Epidemiological Study: home characteristics, indoor pollutants, and subjects'daily activity pattern. Indoor Air 1998;8:70-9.
65. Ramachandran G, Adgate JL, Hill N, Sexton K, Pratt GC, Bock D. Comparison of short-term variation (15-minutes averages) in outdoor and indoor PM 2.5 concentrations. J Air Waste Manag Assoc 2000;50:1157-66.
66. Samet JM, Marbury MC, Spengler JD. Health effects and sources of indoor air pollution. Part I. Am Rev Respir Dis 1987;136:1486-508.
67. Cook DG, Strachan DP, Carey IM. Health effects of passive smoking - 9: parental smoking and spirometric indices in children. Thorax 1998;53:884-93.
68. Venners SA, Wang X, Chen C, Wang B, Ni J, Jin Y et al. Exposure-response relationship between paternal smoking and children's pulmonary function. Am J Respir Crit Care Med 2001;164:973-6.
69. Coultas DB. Health effects of passive smoking-8: passive smoking and risk of adult asthma and COPD: an update. Thorax 1998;53:381-7.
70. Leuenberger P, Schwartz J, Ackermann-Liebrich U, Blaser K, Bolognini G, Bongard JP et al. Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Am J Respir Crit Care Med 1994;150:1222-8.
71. Viegi G, Carrozzi L, Baldacci S, Vellutini M, Paoletti P, Giuntini C. Effetti respiratori dell'esposizione al fumo passivo: stato dell'arte. Atti del Convegno Nazionale "Aria 92" La qualità dell'aria negli ambienti interni, 28-29 Ottobre 1992. Pisa: Dipartimento di Costruzioni Meccaniche e Nucleari, Università degli Studi; 1993.p. 268-73.
72. Eisner MD. Environmental tobacco smoke esposure and pulmonary function among adults in NHANES III: impact on the general population and adults with asthma. Environ Health Perspect 2002;110:765-70.
73. Baldacci S, Pistelli F, Di Pede F, Simoni M, Lo Presti E, Farchi S et al. Respiratory symptoms/diseases are related to environmental tobacco smoke (ETS) in an epidemiological study on environment and health in women from four Italian areas (SEASD). Eur Respir J 2001;18:274s.
74. Neas LM, Dockery DW, Ware JM, Spengler JD, Ferris BJ Jr, Speizer FE. Concentration of indoor particulate matter as a determinant of respiratory health in children. Am J Epidemiol 1994;139:1088-99.
75. Braun-Fahrlander C, Ackermann-Liebrich U, Schwartz J, Gnehm HP, Rutishauser M, Wanner HU. Air pollution and respiratory symptoms in preschool children. Am Rev Respir Dis 1992;145:42-7.
76. Venners SA, Wang B, Ni J, Jin Y, Yang J, Fang Z et al. Indoor air pollution and respiratory health in urban and rural China. Int J Occup Environ Health 2001;7:173-81.
77. Simoni M, Carrozzi L, Baldacci S, Scognamiglio A, Angino A, Pistelli F et al. Acute respiratory effects of indoor pollutants in two general population samples living in a rural and in an urban area of Italy. Proceedings from 9th International Conference on Indoor Air Quality and Climate. Indoor Air 2002. Monterey, California, USA. June 30-July 5, 2002;1:119-24.
78. Garrett MH, Hooper MA, Hooper BM, Abramson MJ. Respiratory symptoms in children and indoor exposure to nitrogen dioxide and gas stoves. Am J Respir Crit Care Med 1998;158:891-5.
79. Jarvis D, Chinn S, Luczynska C, Burney P. Association of respiratory symptoms and lung function in young adults with use of domestic gas appliances. Lancet 1996;347:426-31.
80. Viegi G, Paoletti P, Carrozzi L, Vellutini M, Ballerin L, Biavati P et al. Effects of home environment on respiratory symptoms and lung function in a general population sample in North Italy. Eur Respir J 1991;4:580-6.
81. Krzyzanowski M, Quackenboss JJ, Lebowitz MD. Chronic respiratory effects of indoor formaldehyde exposure. Environ Res 1990;52:117-25.
82. Garrett MH, Hooper MA, Hooper BM, Rayment PR, Abramson MJ. Increased risk of allergy in children due to formaldehyde exposure in homes. Allergy 1999;54:330-7.
83. Pappas GP, Herbert RJ, Henderson W, Koenig J, Stover B, Barnhart S. The respiratory effects of volatile organic compounds. Int J Occup Environ Health 2000;6:1-8.
84. Dales RE, Zwanemburg H, Burnett R, Franklin CA. Respiratory health effects of home dampness and molds among Canadian children. Am J Epidemiol 1991;134:196-203.
85. Murray CS, Woodcock A, Custovic A. Lifestyle and indoor air pollution: allergens. In: D'Amato G, Holgate ST, editors. "The impact of air pollution on respiratory health". Eur Respir Mon 2002;7:133-52.
86. Baldacci S, Viegi G, Carrozzi L, Modena P, Pedreschi M, Di Pede F et al. Respiratory effects due to the presence of pets in the home environment: an epidemiological evaluation. In: Kalliokoski O, Jantunen J, Seppänen O editors. Proceedings of the 6th International Conference on Indoor Air Quality and Climate "Indoor Air '93", Helsinki, Finland, July 4-8, 1993;1:175-9.
87. Rogot E, Sorlie PD, Johnson NJ, Schmitt C. A mortality study of 1.3 million persons by demographic, social, and economic factors: 1979-1985 follow up: US National Longitudinal Mortality Study. NIH publication No 92-3297, National Institutes of Health, National Heart, Lung and Blood Institute, 1992.
88. Benson V, Maramo MA. Current estimates from National Health Interview Survey, 1993. Washington, DC: National Center for Health Statistics, Vital and Health Statistics 1994;10(190). DHHS publication No. (PHS) 95-1518.
89. Carrozzi L, Viegi G, Paoletti P. Fattori di rischio delle malattie respiratorie. In: "Enciclopedia Medica Italiana"-"Respiratorio Apparato". Aggiornamento II, Tomo III, Firenze: USES; 2000.p.5007-21.
90. Watson L, Margetts B, Howarth P, Dorward M, Thompson R, Little P. The association between diet and chronic obstructive pulmonary disease in subjects selected from general practice. Eur Respir J 2002;20:313-8.
91. Sherrill DL, Lebowitz MD, Burrows B. Epidemiology of chronic obstructive pulmonary disease. Clin Chest Med 1990;11:375-87.
92. Tabak C, Smit HA, Heederik D, Ocke MC, Krombout D. Diet and chronic obstructive pulmonary disease: independent beneficial effects of fruits, whole grains, and alcohol (the MORGEN study). Clin Exp Allergy 2001;31:747-55.
93. Viegi G, Scognamiglio A, Baldacci S, Pistelli F, Carrozzi L. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 2001;68:4-19.
94. Sandford AJ, Silverman EK. Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction. Thorax 2002;57:736-41.
95. Churg A, Dai J, Tai H, Xie C, Wright JL. Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 2002;166:849-54.
96. Joost O, Wilk JB, Cupples A, Harmon M, Shearman AM, Baldwin CT et al. Genetic loci influencing lung function. A Genomewide Scan in the Framingham Study. Am J Respir Crit Care Med 2002;165:795-9
97. Viegi G, Carrozzi L, Di Pede F, Baldacci S, Pedreschi M, Modena P et al. Risk factors for chronic obstructive pulmonary disease in a North Italian rural area. Eur J Epid 1994;10:725-31.
98. Shaheen SO, Barker DJ, Holgate ST. Do lower respiratory tract infections in early childhood cause chronic obstructive pulmonary disease? Am J Respir Crit Care Med 1995;151:1649-51.
99. Johnston ID, Strachan DP, Anderson HR. Effect of pneumonia and whooping cough in childhood on adult lung function. N Engl J Med 1998;338:581-7.
100. Carrozzi L, Paoletti P, Prediletto R, Carmignani G, Viegi G, Di Pede F et al. Malattie respiratorie dell'infanzia e predisposizione familiare per malattie dell'apparato respiratorio. Med Torac 1988;10:257-62.
101. Stick SM, Burton PR, Gurrin L, Sly PD, LeSouef PN. Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in new-born infants. Lancet 1996;348:1060-4.
102. Guerra S, Sherrill DL, Bobadilla A, Martinez FD, Barbee RA. The relation of body mass index to asthma, chronic bronchitis, and emphysema. Chest 2002;122:1256-63.
103. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000;117:5-9.
104. Strassels SA. Economic consequences of chronic obstructive pulmonary disease. Curr Opin Pulm Med 1999;5:100-4.
105. Rutten-van Molken MP, Postma MJ, Joore MA, Van Genugten ML, Leidl R, Jager JC. Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. Respir Med 1999;93:779-87.
106. Jansson SA, Andersson F, Borg S, Ericson A, Jonsson E, Lundback B. Costs of COPD in Sweden according to disease severity. Chest 2002;122:1994-2002.
107. Rampulla C, Arossa W, Cerveri I, Viegi G. Stato dell'arte: Broncopneumopatie croniche ostruttive. Epidemiologia ed aspetti socio-economici. Rass Patol Appar Respir 1998;13:460-5.
108. Dal Negro R, Berto P, Tognella S, Quareni L. Global Outcomes in Lung Disease Study Group. Cost-of-illness of lung disease in the TriVeneto Region, Italy: the GOLD study. Monaldi Arch Chest Dis 2002;57:3-9.